Summary
Tryptophan is important both for protein synthesis and as a precursor of niacin, serotonin and other metabolites. Tryptophan is an unusual amino acid because of the complexity of its metabolism, the variety and importance of its metabolites, the number and diversity of the diseases it is involved in, and because of its use in purified form as a pharmacological agent. This review covers the metabolism of tryptophan, its presence in the diet, the disorders associated with low tryptophan levels due to low dietary intake, malabsorption, or high rates of metabolism, the therapeutic effects of tryptophan and the side effects of tryptophan when it is used as a drug including eosinophilia myalgia syndrome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abbott FV, Etienne P, Franklin KBJ, Morgan MJ, Sewitch MJ, Young SN (1992) Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 108: 60–66
Achim CL, Heyes MP, Wiley CA (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 91: 2769–2775
Akiba Y, Takahashi K, Horiguchi M, Ohtani H, Saitoh S, Ohkawara H (1992) L-Tryptophan alleviates fatty liver and modifies hepatic microsomal mixed function oxidase in laying hens. Comp Biochem Physiol 102: 769–774
Altman K, Greengard O (1966) Tryptophan pyrrolase induced in human liver by hydrocortisone: effect on excretion of kynurenine. Science 151: 332–333
Ashley DVM, Barclay DV, Chauffard F, Moennoz D, Leathwood PD (1982) Plasma amino acid responses in humans to evening meals of differing nutritional composition. Am J Clin Nutr 36: 143–153
Ashley DVM, Liardon R, Leathwood PD (1985) Breakfast meal composition influences plasma tryptophan to large neutral amino acid ratios of healthy lean young men. J Neural Transm 63: 271–283
Auffranc JC, Berbis PH, Fabre JF, Garnier JP, Privat Y (1985) Syndrome sclerodermiforme et poikilodermique observe au cours d'un traitment par carbidopa et 5-hydroxy-tryptophan. Ann Dermatol Venereol 112: 691–692
Aviram M, Cogan U, Mokady S (1991) Excessive dietary tryptophan enhances plasma lipid peroxidation in rats. Atherosclerosis 88: 29–34
Baldessarini RJ (1984) Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacol Bull 20: 224–239
Beeken WL (1976) Serum tryptophan in Crohn's disease. Scand J Gastroenterol 11: 735–740
Belongia EA, Hedberg CW, Gleich GJ, White KE, Mayeno AN, Loegering DA, Dunnette SL, Pirie PL, MacDonald KL, Osterholm MT (1990) An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 323: 357–365
Belongia EA, Mayeno AN, Osterholm MT (1992) The eosinophilia-myalgia syndrome and tryptophan. Ann Rev Nutr 12: 235–256
Birkmayer W, Danielczyk W, Neumayer E, Riederer P (1972) The balance of biogenic amines as condition for normal behavior. J Neural Transm 33: 163–178
Birkmayer W, Danielczyk W, Neumayer E, Riederer P (1974) Nucleus rubre and L-dopa psychosis: biochemical post-morten findings. J Neural Transm 35: 93–116
Blauvelt A, Falanga V (1991) Idiopathic and L-tryptophan-associated eosinophilic fascitis before and after L-tryptophan contamination. Arch Dermatol 127: 1159–1166
Blum K, Trachtenberg MC, Cook DW (1990) Neuronutrient effects on weight loss in carbohydrate bingers: an open clinical trial. Curr Ther Res 48: 217–233
Bochner BS, Friedman B, Krishnaswami G, Schleimer RP, Lichtenstein LM, Kroegel C (1991) Episodic Eosinophilia-Myalgia like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony stimulating factor. J Allerg Clin Immunol 88: 629–636
Boman B (1988) L-Tryptophan: a rational anti-depressant and a natural hypnotic. Aust N Z J Psychiatry 22: 83–97
Boulton AA (1979) Trace amines in the central nervous system. In: Tipton KF (ed) International review of biochemistry: physiological and pharmacological biochemistry. University Park Press, Baltimore, pp 179–206
Bryan GT (1971) The role of urinary tryptophan metabolites in the etiology of bladder cancer. Am J Clin Nutr 24: 841–847
Carlson JR, Yokoyama MT, Dickinson EO (1972) Induction of pulmonary edema and emphysema in cattle and goats with 3-methylindole. Science 176: 298–299
Carpenter KJ (1981) Effects of different methods of processing maize on its pellagragenic activity. Federation Proc 40: 1531–1535
Carr L, Ruther E, Berg PA, Lehnert H (1994) Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. Mayo Clin Proc 69: 620–625
Castot A, Bidault I, Bournerias I, Carlier P, Efthymiou ML (1991) Eosinophilia-myalgia syndrome in France: 24 cases. Therapie 46: 355–365
Ceccherelli F, Diani MM, Altafini L, Varotto E, Stefecius A, Casale R, Costola A, Giron GP (1991) Postoperative pain treated by intravenous L-tryptophan: a double-blind study versus placebo in cholecystectomized patients. Pain 47: 163–172
Cho-Chung YS, Pitot HC (1967) Feedback control of rat liver tryptophan pyrrolase: I. End product inhibition of tryptophan pyrrolase activity. J Biol Chem 242: 1192–1198
Christen S, Peterhans E, Stocker R (1990) Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci USA 87: 2506–2510
Clauw DJ, Flockhart DA, Mullins W, Katz P, Medsger TA (1994) Eosinophilia-myaligia syndrome not associated with the ingestion of nutritional supplements. J Rheumatol 21: 2385–2387
Coccaro EF (1992) Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship. Int Clin Psychopharmacol 7: 3–12
Cole JO, Hartmann E, Brigham P (1980) L-Tryptophan: clinical studies. In: Cole JO (ed) Psychopharmacology update. Collamore Press, Lexington, MA, pp 119–148
Cooper AJ (1979) Tryptophan antidepressant “physiological sedative”: fact or fancy? Psychopharmacology 61: 97–102
Coppen A, Megcalfe M, Carroll JD, Morris JGL (1972) Levodopa and L-tryptophan therapy in parkinsonism. Lancet i: 654–658
Cosgrove JW, Verney E, Schwartz AM, Sidransky H (1992) Tryptophan binding to nuclei of rat brain. Exp Mol Pathol 57: 180–192
Crofford LJ, Rader JI, Dalakas MC, Hill RH, Page SW, Needham LL, Brady LS, Heyes MP, Wilder RL, Gold PW, Smith C, Sternberg EM (1990) L-Tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J Clin Invest 86: 1757–1763
Curzon G, Knott PJ (1974) Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br J Pharmacol 50: 197–204
DeMeyer MK, Shea PA, Hendrie HC, Yoshimura NN (1981) Plasma tryptophan and five other amino acids in depressed and normal subjects. Arch Gen Psychiatry 38: 642–646
Dunlop SR, Hendrie HC, Shea PA, Brittain HM (1983) Ratio of plasma tryptophan to five other amino acids in depressed subjects: a follow-up. Arch Gen Psychiatry 40: 1033–1034
Ekblom A, Hansson P, Thomsson M (1991) L-Tryptophan supplementation does not affect postoperative pain intensity or consumption of analgesics. Pain 44: 249–254
Emerit MB, Riad M, Hamon M (1992) Trophic effects of neurotransmitters during brain maturation. Biol Neonate 62: 193–201
Etienne P, Young SN, Sourkes TL (1976) Inhibition by albumin of tryptophan uptake by rat brain. Nature 262: 144–145
Fahn S, Snider S, Prasad ALN, Lane E, Makadon H (1975) Normalization of brain serotonin by L-tryptophan in levodopa-treated rats. Neurology 25: 861–865
Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173: 149–152
Flockhart DA, Clauw DJ, Sale EB, Hewett J, Woosley RL (1994) Pharmacogenetic characteristics of the eosinophilia-myalgia syndrome. Clin Pharmacol Ther 56: 398–405
Franklin KBJ, Abbott FV, English MJM, Jeans ME, Tasker RAR, Young SN (1990) Tryptophan-morphine interactions and postoperative pain. Pharmacol Biochem Behav 35: 157–163
Friedman M, Cuq JL (1988) Chemistry, analysis, nutritional value and toxicology of tryptophan in food: a review. J Agric Food Chem 36: 1079–1093
Fuchs D, Forsman A, Hagberg L, Larsson M, Norkrans G, Reibnegger G, Werner ER, Wachter H (1990a) Immune activation and decreased tryptophan in patients with HIV-1 infection. J Interferon Res 10: 599–603
Fuchs D, Möller AA, Reibnegger G, Stöckle E, Werner ER, Wachter H (1990b) Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acq Immune Def Synd 3: 873–876
Fuchs D, Möller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H (1991) Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett 28: 207–212
Fujiki H, Suganuma M, Tahira T, Esumi M, Nagao N, Wakabayashi K, Sugimura T (1984) New biological significance of indole-containing compounds as initiators or tumor promoters in chemical carcinogenesis. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter, Berlin, pp 793–802
Funk DN, Worthington-Roberts B, Fantel A (1991) Impact of supplemental lysine or tryptophan on pregnancy course and outcome in rats. Nutr Res 11: 501–512
Gehlen W, Müller J (1974) Zur Therapie der Dopa-Psychosen mit L-Tryptophan. Dtsch Med Wochenschr 99: 457–463
Gerson SC, Baldessarini RJ (1980) Motor effects of serotonin in the central nervous system. Life Sci 27: 1435–1451
Gessa GL, Tagliamonte A (1974) Possible role of free serum tryptophan in the control of brain tryptophan level and serotonin synthesis. In: Costa E, Gessa GL, Sandler M (eds) Serotonin — new vistas: biochemistry and behavioral and clinical studies: advances in biochemical psychopharmacology, vol 11. Raven Press, New York, pp 119–131
Gillin JC, Kaplan JA, Wyatt RJ (1976) Clinical effects of tryptophan in chronic schizophrenic patients. Biol Psychiatry 11: 635–639
Glaeser BS, Maher TJ, Wurtman RJ (1983) Changes in brain levels of acidic, basic, and neutral amino acids after consumption of single meals containing various proportions of proteins. J Neurochem 41: 1016–1021
Golberger J, Wheeler GA (1915) Experimental pellagra in the human subject brought about by a restricted diet. Public Health Rep 30: 3336–3339
Green AR, Sourkes TL, Young SN (1975) Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils. Br J Pharmacol 53: 287–292
Gullino P, Winitz M, Birnbaum M, Cornfield J, Otey MC, Greenstein JP (1956) Studies on the metabolism of amino acids and related compoundsin vivo. I. Toxicity of essential amino acids, individually and in mixtures and the protective effect of L-arginine. Arch Biochem Biophys 64: 319–332
Hallert C, Anström J (1982) Psychic disturbances in adult coeliac disease. II. Psychological findings. Scand J Gastroenterol 17: 21–24
Hallert C, Sedvall G (1983) Improvement in central monoamine metabolism in adult coeliac patients starting a gluten-free diet. Psychol Med 13: 267–271
Hallert C, Anström J, Sedvall G (1982a) Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression. Scand J Gastroenterol 17: 25–28
Hallert C, Martensson J, Allgen LG (1982b) Brain availability of monoamine precursors in adult coeliac disease. Scand J Gastroenterol 17: 87–89
Harper AE, Benevenga NJ, Wohlhueter RM (1970) Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev 50: 428–558
Harper AE, Yoshimura NN (1993) Protein quality, amino acid balance, utilization, and evaluation of diets containing amino acids as therapeutic agents. Nutrition 9: 460–469
Hartmann E, Cravens J, List S (1974) Hypnotic effects of L-tryptophan. Arch Gen Psychiatry 31: 394–397
Hartmann E, Greenwald D (1984) Tryptophan and human sleep: an analysis of 43 studies. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter, Berlin, pp 297–304
Hattori M, Kotake Y, Otsuka H, Shibata Y (1984) Studies on the urinary excretion of xanthurenic acid in diabetics. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter, Berlin, pp 347–354
Hernanz A, Polanco I (1991) Plasma precursor amino acids of central nervous system monoamines in children with coeliac disease. Gut 32: 1478–1481
Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ (1990) Association of the eosinophilia syndrome with ingestion of tryptophan. N Engl J Med 322: 869–873
Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, Rubinow D, Markey SP (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29: 202–209
Hibbs JR, Mittleman B, Hill P, Medsger TA (1992) L-Tryptophan associated eosinophilic fasciitis prior to the 1989 eosinophilia myalgia syndrome outbreak. Arthritis Rheum 35: 299–303
Hill RH, Caudill SP, Philen RM, Bailey SL, Flanders WD, Driskell WJ, Kamb ML, Needham LL, Sampson EJ (1993) Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome. Arch Environ Contam Toxicol 25: 134–142
Hirata Y, Kawachi T, Sugimura T (1967) Fatty liver induced by injection of L-tryptophan. Biochim Biophys Acta 144: 233–241
Hopkins FG, Cole SW (1901) A contribution to the chemistry of proteins. Part 1. A preliminary study of a hitherto undescribed product of tryptic digestion. J Physiol 27: 418–428
Hornstein OP, Olszewsky ME, Flugel D, Kaschka WP (1989) Kann Lithium-Therapie eine progressive systemische Sklerodermie oder eosinophile Fascitis auslösen? Nervenheilkunde 8: 239–242
Horwitt MK, Harvey CC, Rothwell WS, Cutler JL, Haffron D (1956) Tryptophan-niacin relationships in men: studies with diets deficient in riboflavin and niacin together with observations on the excretion of nitrogen and niacin metabolites. J Nutr 60 [Suppl] 1: 1–43
Horwitt MK, Harper AE, Henderson LM (1981) Niacin-tryptophan relationships for evaluating niacin equivalents. Am J Clin Nutr 34: 423–427
Huether G, Hajak G, Reimer A, Poeggeler B, Blomer M, Rodenbeck A, Ruther E (1992a) The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacology 109: 422–432
Huether G, Poeggeler B, Reimer A, George A (1992b) Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 51: 945–953
Huether G, Thomke F, Adler L (1992c) Administration of tryptophan-enriched diets to pregnant rats retards the development of the serotonergic system in their offspring. Dev Brain Res 68: 175–181
Ikeda S, Kotake Y (1984) Urinary excretion of xanthurenic acid and zinc in diabetes. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter, Berlin, pp 355–358
Ito J, Hosaki Y, Torigoe Y, Sakimoto K (1992) Identification of substances formed by decomposition of Peak E-substance in tryptophan. Food Chem Toxicol 30: 71–81
Iwata H, Okamoto H, Koh S (1975) Effects of various drugs on serum free and total tryptophan levels and brain tryptophan metabolism in rats. Jpn J Pharmacol 25: 303–310
Jaeger W, Käfer O, Schmidt H, Lutz P (1979) Bilateral optic atrophy in childhood caused by tryptophan deficiency. Metab Pediatr Ophthalmol 3: 167–169
Johnson DJ, Anderson GH (1982) Prediction of plasma amino acid concentration from diet amino acid content. Am J Physiol 243: R99-R103
Joseph MS, Brewerton TD, Reus VI, Stebbins GT (1984) Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression. Psychiatry Res 11: 185–192
Kamb ML, Murphy JJ, Jones JL, Caston JC, Nederlof K, Horney LF, Swygert LA, Falk H, Kilbourne EM (1992) Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients. J Am Med Assoc 267: 77–82
Katz SH, Hediger ML, Valleroy LA (1974) Traditional maize processing techniques in the new world: traditional alkali processing enhances the nutritional quality of the maize. Science 184: 765–773
Kaufman LD, Gruber BL, Gregersen PK (1991) Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome. Lancet 337: 1071–1074
Kelly WF, Checkley SA, Bender DA (1980) Cushing's syndrome, tryptophan and depression. Br J Psychiatry 136: 125–132
Kilbourne EM, Swygert LA, Philen RM, Sun RK, Aurbach SB, Miller L, Nelson DE, Falk H (1990) Interim guidance on the eosinophilia-myalgia syndrome. Ann Intern Med 112: 85–86
King RB (1980) Pain and tryptophan. J Neurosurg 53: 44–52
Knox WE (1966) The regulation of tryptophan pyrrolase activity by tryptophan. Adv Enzyme Regul 4: 287–297
Krebs HA (1971) Reflections on the role of tryptophan derivatives on metabolic regulations. In: Guy KE, Carlson LA (eds) Metabolic effects of nicotinic acid and its derivatives: proceedings of a workshop at flims. Huber, Bern, pp 1115–1118
Lader M (1994) The return of L-tryptophan. Hum Psychopharmacology 9: 365–366
Lappin RI, Auchinloss EL (1994) Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 331: 1021–1022
Lauer JW, Inskip WM, Bernsohn J, Zeller EA (1958) Observations on schizophrenic patients after iproniazid and tryptophan. A M A Arch Neurol Psychiatr 80: 122–130
Lehmann J (1972) Mental and neuromuscular symptoms in tryptophan deficiency. Acta Psychiatr Scand [Suppl] 237: 1–28
Lehmann J (1973) Tryptophan malabsorption in levodopa-treated parkinsonian patients: effect of tryptophan on mental disturbances. Acta Med Scand 194: 181–189
Lehmann J (1981) Tryptophan malabsorption in dementia: improvement in certain cases after tryptophan therapy as indicated by mental behaviour and blood analysis. Acta Psychiatr Scand 64: 123–131
Lejoyeux M, Adès J, Rouillon F (1994) Serotonin syndrome: incidence, symptoms and treatment. CNS Drugs 2: 132–143
Leklem JE (1971) Quantitative aspects of tryptophan metabolism in humans and other species: a review. Am J Clin Nutr 24: 659–672
Lewander T, Sjöstrom R (1973) Increase in plasma concentration of free tryptophan caused by probenecid in humans. Psychopharmacology 33: 81–86
Lieberman HR, Caballero B, Finer N (1986) The composition of lunch determines afternoon plasma tryptophan ratios in humans. J Neural Transm 65: 211–217
Love LA, Rader JI, Crofford LJ, Raybourne RB, Principato MA, Page SW, Trucksess MW, Smith MJ, Dugan EM, Turner ML, Zelazowski E, Zelazowski P, Sternberg EM (1993) Pathological and immunological effects of ingesting L-tryptophan and 1,1′-ethylidenebis(L-tryptophan) in Lewis rats. J Clin Invest 91: 804–811
Lucca A, Lucini V, Piatti E, Ronchi P, Smeraldi E (1992) Plasma tryptophan levels and plasma tryptophan/neutral amino acids ratio in patients with mood disorder, patients with obsessive-compulsive disorder, and normal subjects. Psychiatry Res 44: 85–91
Madara JL, Carlson S (1991) Supraphysiologic L-tryptophan elicits cytoskeletal and macromolecular permeability alterations in hamster small intestinal epithelium in vitro. J Clin Invest 87: 454–462
Maes M, Vandewoude M, Schotte C, Martin M, D'Hondt P, Scharpe S, Blockx P (1990) The decreased availability of L-tryptophan in depressed females: clinical and biological correlates. Prog Neuropsychopharmacol Biol Psychiatry 14: 903–919
Maestroni GJM (1993) Mini-review: the immunoneuroendocrine role of melatonin. J Pineal Res 14: 1–10
Manabe S, Wada O (1990) Identification of carcinogenic tryptophan pyrolysis products in human bile by high-performance liquid chromatography. Environ Mol Mutagen 15: 229–235
Matsuo S, Inoue F, Takeuchi Y, Yoshioka H, Kinugasa A, Sawada T (1995) Efficacy of tryptophan for the treatment of nonketotic hyperglycinemia: a new therapeutic approach for modulating the N-methyl-D-aspartate receptor. Pediatrics 95: 142–146
Matthies DL, Jacobs FA (1993) Rat liver is not damaged by high dose tryptophan treatment. J Nutr 123: 852–859
Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ (1990) Characterization of “Peak E,” a ovel amino acid associated with eosinophiliamyalgia syndrome. Science 250: 1707–1708
McArthur JN, Dawkins PD, Smith MJH (1971a) The displacement of L-tryptophan and dipeptides from bovine serum albuminin vitro and from human plasmain vivo by antirheumatic drugs. J Pharm Pharmacol 23: 393–398
McArthur JN, Dawkins PD, Smith MJH, Hamilton EBD (1971b) Mode of action of antirheumatic drugs. Br Med J 2: 677–679
McGrath RE, Buckwald B, Resnick EV (1990) The effect of L-tryptophan on seasonal affective disorder. J Clin Psychiatry 51: 162–163
McMenamy RH, Oncley JL (1958) The specific binding of L-tryptophan to serum albumin. J Biol Chem 233: 1436–1447
McMenamy RH (1964) The binding of indole analogues to defatted human serum albumin at different chloride concentrations. J Biol Chem 239: 2835–2841
Meier AH, Wilson JH (1983) Tryptophan feeding adversely influences pregnancy. Life Sci 32: 1193–1196
Meltzer HY, Lowy MT (1987) The serotonin hyptothesis of depression. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 513–526
Michelson D, Page SW, Casey R, Trucksess MW, Love LA, Milstien S, Wilson C, Massaquoi SG, Crofford LJ, Hallett M, Gold PW, Sternberg EM (1994) An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan. J Rheumatol 21:2261–2265
Miller EM, Nieburg HA (1974) L-Tryptophan in the treatment of levodopa induced psychiatric disorders. Dis Nerv Syst 35: 20–23
Mizutani T, Mizutani H, Hashimoto K, Nakamura Y, Kishida M, Taniguchi H, Murata M, Kuzuhara S, Shimizu M (1991) Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan. J Am Acad Dermatol 25: 512–517
Moldofsky H, Lue FA (1980) The relationship of alpha and delta EEG frequencies to pain and mood in “fibrositis” patients treated with chlorpromazine and L-tryptophan. EEG Clin Neurophysiol 50: 71–80
Moller SE (1990) Plasma neutral amino acids associated with the efficacy of antidepressant treatment: a summary. In: Richardson MA (ed) Amino acids in psychiatric disease. American Psychiatric Press, Inc., Bethesda, pp 99–129
Morand C, Young SN, Ervin FR (1983) Clinical response of aggressive schizophrenics to oral tryptophan. Biol Psychiatry 18: 575–578
Moroni F, Russi P, Lombardi G, Carlá V, Alesiani M, Cherici G, Moneti G (1990) Tryptophan metabolites and excitatory amino acid receptors: studies in physiology and pathology. In: Guidotti A (ed) Neurotoxicity of excitatory amino acids. Raven Press, New York, pp 203–216
Murphy DL, Baker M, Goodwin FK, Miller H, Kotin J, Bunney WE (1974) L-Tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia 34: 11–20
Müller WE, Wollert U (1975) Benzodiazepines: specific competitors for the binding of L-tryptophan to human serum albumin. Naunyn Schmiedebergs Arch Pharmacol 288: 17–27
National Cancer Institute (1978) Bioassay of L-tryptophan for possible carcinogenicity. National Cancer Institute Carcinogenesis Technical Report Series No. 71 (DHEW Publication No. (NIH) 78-1321). US Government Printing Office, Washington, DC
National Reserarch Council (1989) Recommended daily allowances. National Academy Press, Washington, DC, pp 1–285
Oldendorf WH, Szabo J (1976) Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am J Physiol 230: 94–98
Paradis MR, Breeze RG, Bayly WM, Counts DF, Laegreid WW (1991) Acute hemolytic anemia after oral administration of L-tryptophan to ponies. Am J Vet Res 52: 742–747
Pfefferkorn ER, Rebhun S, Eckel M (1986) Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J Interferon Res 6: 267–279
Philen RM, Hill RH, Flanders WD, Caudill SP, Needham L, Sewell L, Sampson EJ, Falk H, Kilbourne EM (1993) Tryptophan contaminants associated with eosinophiliamyalgia syndrome. Am J Epidemiol 138: 154–159
Rabey JM, Vardi J, Askenazi JJ, Streifler M (1977) L-Tryptophan administration in L-dopa-induced hallucinations in elderly parkinsonian patients. Gerontology 23: 438–444
Reiter RJ (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12: 151–180
Rosenberg LE, Scriver CR (1974) Disorders of amino acid metabolism. In: Bondy PK, Rosenberg LE (eds) Duncan's diseases of metabolism: genetics and metabolism. W.B. Saunders Company, Philadelphia, pp 465–633
Rothschild MA, Oratz M, Mongelli J, Schreiber SS (1971) Alcohol-induced depression of albumin synthesis: reversal by tryptophan. J Clin Invest 50: 1812–1818
Sainio EL, Sainio P (1990) Comparison of the effects of nicotinic acid and tryptophan on tryptophan 2,3-dioxygenase in acute and chronic studies. Toxicol Appl Pharmacol 102: 251–258
Sainio EL, Närvänen S, Sainio P, Tuohimaa P (1991) Distribution of tryptophan in normal and glucose loaded mice. Amino Acids 1: 160
Sato F, Shimooka H, Sakakibara M, Kawase Y (1992) Effects of metyrapone and L-tryptophan administration on eosinophils in peripheral blood of mouse. Toxicol Lett 62: 323–324
Sebrell WH (1981) History of pellagra. Federation Proc 40: 1520–1522
Segall PE, Timiras PS (1983) Low tryptophan diets delay reproductive aging. Mech Ageing Dev 23: 245–252
Segura R, Ventura JL (1988) Effect of L-tryptophan supplementation on exercise performance. Int J Sports Med 9: 301–305
Seltzer S, Dewart D, Pollack RL, Jackson EJ (1983) The effects of dietary tryptophan on chronic maxillofacial pain and experimental pain tolerance. J Psychiat Res 17: 181–185
Shishikura T, Tsuchiya T, Sato F, Oguro K, Ebisawa H (1991) Eosinophilia caused by administration of L-tryptophan to animals with adrenal dysfunction. Toxicol Lett 58: 315–321
Shpeen SE, Morse DR, Furst ML (1984) The effect of tryptophan on postoperative endodontic pain. Oral Surg 58: 446–449
Sidransky H, Sarma DSR, Bongiorno M, Verney E (1968) Effect of dietary tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. J Biol Chem 243: 1123–1132
Sidransky H, Verney E, Kurl RN, Razavi T (1988) Effect of tryptophan on toxic cirrhosis induced by intermittent carbon tetrachloride intoxication in the rat. Exp Mol Pathol 49: 102–110
Silver RM, Heyes MP, Maize JC, Quearry B, Vionnetfuasset M, Sternberg EM (1990) Scleroderma, fascitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 322: 874–881
Sjoerdsma A, Weissbach H, Udenfriend S (1956) A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Am J Med 20: 520–532
Smith MJ, Mazzola EP, Farrell TJ, Sphon JA, Page SW, Asley D, Sirimanne SR, Hill RH, Needham LL (1991) 1,1′-Ethylidenebis (L-tryptophan), structure determination of contaminant “97” — implicated in the eosinophilia-myalgia syndrome (EMS). Tet Letters 32: 991–994
Sofic E, Riederer P, Schmidt B, Fritze J, Kollegger H, Dierks T, Beckmann H (1992) Biogenic amines and metabolites in CSF from patients with HIV infection. Biogen Amines 8: 293–298
Soubrié P (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 9: 319–364
Souci SW, Fachmann W, Kraut H (1986) Food composition and nutrition tables 1986/1987. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
Sourkes TL (1983) Toxicology of monoamine precursors. In: van Praag HM, Mendlewicz J (eds) Management of depressions with monoamine precursors: Advances in biological psychiatry, Vol 10. S. Karger, Basel, pp 160–175
Spano PF, Szyszka K, Pozza G, Sirtori CR (1974) Influence of clofibrate on serum tryptophan in man. Res Exp Med 163: 265–269
Spoont MR (1992) Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull 112: 330–350
Steiner W, Fontaine R (1986) Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports. Biol Psychiatry 21: 1067–1071
Stensrud T, Ingjer F, Holm H, Stromme SB (1992) L-Tryptophan supplementation does not improve running performance. Int J Sports Med 13: 481–485
Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148: 705–713
Sternbach RA, Janowsky DS, Huey LY, Segal DS (1976) Effects of altering brain serotonin activity on human chronic pain. In: Bonica JJ, Albe-Fessard D (eds) Advances in pain research and therapy. Raven Press, New York, pp 601–606
Sternberg EM, Van Woert HM, Young SN, Magnussen L, Baker H, Gauthier S, Osterland CK (1980) Development of a scleroderma-like illness during L-5HTP-carbidopa therapy. N Engl J Med 303: 782–787
Strain GW, Strain JJ, Zumoff B (1985) L-Tryptophan does not increase weight loss in carbohydrate-craving obese subjects. Int J Obes 9: 375–380
Sweet RD, McDowell FH, Feigenson JS, Loranger AW, Goodell H (1976) Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 26: 305–310
Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM (1990) Eosinophiliamyalgia syndrome: results of a national survey. J Am Med Assoc 264: 1698–1703
Taylor MW, Feng G (1991) Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5: 2516–2522
Teff KL, Young SN, Blundell JE (1989a) The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males. Pharmacol Biochem Behav 34: 829–837
Teff KL, Young SN, Marchand L, Botez MI (1989b) Acute effect of protein and carbohydrate breakfasts on human cerebrospinal fluid monoamine precursor and metabolite levels. J Neurochem 52: 235–241
Thomson J, Rankin H, Ashcroft GW, Yates CM, McQueen JK, Cummings SW (1982) The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychol Med 12: 741–751
Trulson ME, Sampson HW (1986) Ultrastructural changes of the liver following L-tryptophan ingestion in rats. J Nutr 116: 1109–1115
Virkkunen M, DeJong J, Bartko J, Goodwin FK, Linnoila M (1989) Relationships of psychobiological variables to recidivism in violent offenders and impulsive fire setters: a followup study. Arch Gen Psychiatry 46: 601–603
Volavka J, Crowner M, Brizer D, Convit A, van Praag HM, Suckow RF (1990) Tryptophan treatment of aggressive psychiatric inpatients. Biol Psychiatry 28: 728–732
Wilkins K (1990) Eosinophilia-myalgia syndrome. Can Med Assoc J 142: 1265–1266
Wolf H (1974) Studies on tryptophan metabolism in man. Scand J Clin Lab Invest [Suppl] 136: 1–186
World Health Organization (1992) Toxic oil syndrome: current knowledge and future perspectives. WHO Regional Publications, European Series, No. 42. World Health Organization, Copenhagen
Wurtman JJ, Wurtman RJ, Growdon JH, Henry P, Lipscomb A, Zeisel SH (1981a) Carbohydrate craving in obese people: suppression by treatments affecting serotoninergic transmission. Int J Eating Dis 1: 2–15
Wurtman RJ, Hefti F, Melamed E (1981b) Precursor control of neurotransmitter synthesis. Pharmacol Rev 32: 315–335
Xue-Cun C, Tai-An Y, Xiu-Zhen T, Yu-Fang H, Xiao-Yue Y, Shu-Rong L, Huai-Cheng Y (1983) Opaque-2 maize in the prevention and treatment of pellagra. Nutr Res 3: 171–180
Young SN, Sourkes TL (1977) Tryptophan in the central nervous system: regulation and significance. In: Agranoff BW, Aprison MH (eds) Advances in neurochemistry, vol 2. Plenum Press, New York, pp 133–191
Young SN, Gauthier S (1981) Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 44: 323–327
Young SN (1986) The clinical psychopharmacology of tryptophan. In: Wurtman RJ, Wurtman JJ (eds) Nutrition and the brain, vol 7. Food constituents affecting normal and abnormal behaviors. Raven Press, New York, pp 49–88
Young SN (1990) Factors influencing the therapeutic effect of tryptophan in affective disorders, sleep, aggression, and pain. In: Richardson MA (ed) Amino acids in psychiatric disease. American Psychiatric Press, Inc., Washington, DC, pp 51–75
Young SN (1991) Use of amine precursors in combination with other antidepressant treatments: a review. J Psychiatr Neurosci 16: 241–246
Yuwiler A, Geller E (1973) Rat liver tryptophan oxygenase induced by neonatal corticoid administration and its effect on brain serotonin. Enzyme 15: 161–168
Yuwiler A, Oldendorf WH, Geller E, Braun L (1977) Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem 28: 1015–1023
Zigman S (1984) The role of tryptophan oxidation in ocular tissue damage. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter, Berlin, pp 449–467
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sainio, E.L., Pulkki, K. & Young, S.N. L-Tryptophan: Biochemical, nutritional and pharmacological aspects. Amino Acids 10, 21–47 (1996). https://doi.org/10.1007/BF00806091
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00806091